[
  {
    "case_id": "SL_001",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.44405918068595746
      },
      "clinical_evidence": {
        "pmid": "25366685",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_002",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.5136549385283461
      },
      "clinical_evidence": {
        "pmid": "28569902",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_003",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32340314,
        "ref": "C",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_000059.4(BRCA2):c.9976A>T (p.K3326*); genomic Chr13:32340314 on GRCh37",
        "_mapping_key": "BRCA2|p.K3326*",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.5785124303033135
      },
      "clinical_evidence": {
        "pmid": "25366685",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_004",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32340314,
        "ref": "C",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_000059.4(BRCA2):c.9976A>T (p.K3326*); genomic Chr13:32340314 on GRCh37",
        "_mapping_key": "BRCA2|p.K3326*",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.49663622684497655
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_005",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "MBD4",
        "hgvs_p": "p.Trp569Ter",
        "chrom": "3",
        "pos": 129150847,
        "ref": "G",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_003925.3(MBD4):c.1706G>A (p.Trp569*); GRCh37 chr3:129150847.",
        "_mapping_key": "MBD4|p.R346fs",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "MBD4+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "BER"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "MBD4": 0.12484960719544597
      },
      "clinical_evidence": {
        "pmid": "30111527",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_006",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "33115855",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_007",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+WEE1"
      ],
      "effective_drugs": [
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_008",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "ATM",
        "hgvs_p": "p.Val2424Gly",
        "chrom": "11",
        "pos": 108236235,
        "ref": "G",
        "alt": "A",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_000051.4(ATM):c.7271T>G; GRCh37 chr11:108236235; ClinVar VCV000003023, RCV000115244. [AUTOREF 2026-01-19 ref:T->G]",
        "_mapping_key": "ATM|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ATM+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "ATM": 0.03199998891214332
      },
      "clinical_evidence": {
        "pmid": "29880560",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_009",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "PALB2",
        "hgvs_p": "p.Arg1086Ter",
        "chrom": "16",
        "pos": 23641422,
        "ref": "A",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_024675.4(PALB2):c.3256C>T; GRCh37 chr16:23641422; ClinVar VCV000126729. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "PALB2|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "PALB2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "PALB2": 0.4837245019947514
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_010",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.7061312400750432
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_011",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51D",
        "hgvs_p": "p.Ser207Leu",
        "chrom": "17",
        "pos": 33428695,
        "ref": "G",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_002878.4(RAD51D):c.620C>T; GRCh37 chr17:33428695. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "RAD51D|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51D+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51D": 0.7293221853155034
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_012",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "ARID1A",
        "hgvs_p": "p.Arg1209Ter",
        "chrom": "1",
        "pos": 27106114,
        "ref": "G",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_006015.6(ARID1A):c.3625C>T; GRCh37 chr1:27106114. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "ARID1A|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ARID1A+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "ARID1A": 0.375561921664032
      },
      "clinical_evidence": {
        "pmid": "30510156",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_013",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.4085607197529356
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_014",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.5136549385283461
      },
      "clinical_evidence": {
        "pmid": "25366685",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_015",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.31676202596271663
      },
      "clinical_evidence": {
        "pmid": "28569902",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_016",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32340314,
        "ref": "C",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_000059.4(BRCA2):c.9976A>T (p.K3326*); genomic Chr13:32340314 on GRCh37",
        "_mapping_key": "BRCA2|p.K3326*",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.49663622684497655
      },
      "clinical_evidence": {
        "pmid": "25366685",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_017",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32340314,
        "ref": "C",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_000059.4(BRCA2):c.9976A>T (p.K3326*); genomic Chr13:32340314 on GRCh37",
        "_mapping_key": "BRCA2|p.K3326*",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.5194046762092465
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_018",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "MBD4",
        "hgvs_p": "p.Trp569Ter",
        "chrom": "3",
        "pos": 129150847,
        "ref": "G",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_003925.3(MBD4):c.1706G>A (p.Trp569*); GRCh37 chr3:129150847.",
        "_mapping_key": "MBD4|p.R346fs",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "MBD4+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "BER"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "MBD4": 0.1133053958772785
      },
      "clinical_evidence": {
        "pmid": "30111527",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_019",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "33115855",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_020",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+WEE1"
      ],
      "effective_drugs": [
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_021",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "ATM",
        "hgvs_p": "p.Val2424Gly",
        "chrom": "11",
        "pos": 108236235,
        "ref": "G",
        "alt": "A",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_000051.4(ATM):c.7271T>G; GRCh37 chr11:108236235; ClinVar VCV000003023, RCV000115244. [AUTOREF 2026-01-19 ref:T->G]",
        "_mapping_key": "ATM|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ATM+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "ATM": 0.05858248553710228
      },
      "clinical_evidence": {
        "pmid": "29880560",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_022",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "PALB2",
        "hgvs_p": "p.Arg1086Ter",
        "chrom": "16",
        "pos": 23641422,
        "ref": "A",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_024675.4(PALB2):c.3256C>T; GRCh37 chr16:23641422; ClinVar VCV000126729. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "PALB2|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "PALB2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "PALB2": 0.33189795944643924
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_023",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.7042390620749244
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_024",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51D",
        "hgvs_p": "p.Ser207Leu",
        "chrom": "17",
        "pos": 33428695,
        "ref": "G",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_002878.4(RAD51D):c.620C>T; GRCh37 chr17:33428695. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "RAD51D|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51D+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51D": 0.5788916280524823
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_025",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "ARID1A",
        "hgvs_p": "p.Arg1209Ter",
        "chrom": "1",
        "pos": 27106114,
        "ref": "G",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_006015.6(ARID1A):c.3625C>T; GRCh37 chr1:27106114. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "ARID1A|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ARID1A+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "ARID1A": 0.2596675073474911
      },
      "clinical_evidence": {
        "pmid": "30510156",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_026",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.48274278092286904
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_027",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.31676202596271663
      },
      "clinical_evidence": {
        "pmid": "25366685",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_028",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.44405918068595746
      },
      "clinical_evidence": {
        "pmid": "28569902",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_029",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32340314,
        "ref": "C",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_000059.4(BRCA2):c.9976A>T (p.K3326*); genomic Chr13:32340314 on GRCh37",
        "_mapping_key": "BRCA2|p.K3326*",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.5194046762092465
      },
      "clinical_evidence": {
        "pmid": "25366685",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_030",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32340314,
        "ref": "C",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_000059.4(BRCA2):c.9976A>T (p.K3326*); genomic Chr13:32340314 on GRCh37",
        "_mapping_key": "BRCA2|p.K3326*",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.5785124303033135
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_031",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "MBD4",
        "hgvs_p": "p.Trp569Ter",
        "chrom": "3",
        "pos": 129150847,
        "ref": "G",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_003925.3(MBD4):c.1706G>A (p.Trp569*); GRCh37 chr3:129150847.",
        "_mapping_key": "MBD4|p.R346fs",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "MBD4+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "BER"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "MBD4": 0.1174664233026257
      },
      "clinical_evidence": {
        "pmid": "30111527",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_032",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "33115855",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_033",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+WEE1"
      ],
      "effective_drugs": [
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_034",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "ATM",
        "hgvs_p": "p.Val2424Gly",
        "chrom": "11",
        "pos": 108236235,
        "ref": "G",
        "alt": "A",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_000051.4(ATM):c.7271T>G; GRCh37 chr11:108236235; ClinVar VCV000003023, RCV000115244. [AUTOREF 2026-01-19 ref:T->G]",
        "_mapping_key": "ATM|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ATM+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "ATM": 0.028631024194835045
      },
      "clinical_evidence": {
        "pmid": "29880560",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_035",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "PALB2",
        "hgvs_p": "p.Arg1086Ter",
        "chrom": "16",
        "pos": 23641422,
        "ref": "A",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_024675.4(PALB2):c.3256C>T; GRCh37 chr16:23641422; ClinVar VCV000126729. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "PALB2|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "PALB2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "PALB2": 0.3409024137324467
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_036",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.6334293589307343
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_037",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51D",
        "hgvs_p": "p.Ser207Leu",
        "chrom": "17",
        "pos": 33428695,
        "ref": "G",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_002878.4(RAD51D):c.620C>T; GRCh37 chr17:33428695. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "RAD51D|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51D+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51D": 0.7360546282435787
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_038",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "ARID1A",
        "hgvs_p": "p.Arg1209Ter",
        "chrom": "1",
        "pos": 27106114,
        "ref": "G",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_006015.6(ARID1A):c.3625C>T; GRCh37 chr1:27106114. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "ARID1A|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ARID1A+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "ARID1A": 0.2762992755625062
      },
      "clinical_evidence": {
        "pmid": "30510156",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_039",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.42475616619423795
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_040",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.44405918068595746
      },
      "clinical_evidence": {
        "pmid": "25366685",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_041",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_042",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_043",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_044",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_045",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_046",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_047",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_048",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_049",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_050",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_051",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_052",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_053",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_054",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_055",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_056",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_057",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_058",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_059",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_060",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_061",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_062",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_063",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_064",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_065",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_066",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_067",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_068",
    "disease": "ovarian_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_069",
    "disease": "breast_cancer",
    "mutations": [
      {
        "gene": "KRAS",
        "hgvs_p": "p.G12D",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "12",
        "pos": 25398284,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_004985.5(KRAS):c.35G>A; genomic Chr12:25398284 on GRCh37",
        "_mapping_key": "KRAS|p.G12D",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Trametinib"
      ]
    }
  },
  {
    "case_id": "SL_070",
    "disease": "prostate_cancer",
    "mutations": [
      {
        "gene": "EGFR",
        "hgvs_p": "p.L858R",
        "consequence": "missense",
        "build": "GRCh38",
        "chrom": "7",
        "pos": 55259515,
        "ref": "G",
        "alt": "A",
        "_mapping_note": "NM_005228.5(EGFR):c.2573T>G (p.L858R); genomic Chr7:55259515 on GRCh37",
        "_mapping_key": "EGFR|p.L858R",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": false,
      "known_sl_pairs": [],
      "effective_drugs": [
        "Osimertinib"
      ]
    }
  },
  {
    "case_id": "SL_071",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.6334293589307343
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_072",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "ARID1A",
        "hgvs_p": "p.Arg1209Ter",
        "chrom": "1",
        "pos": 27106114,
        "ref": "G",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_006015.6(ARID1A):c.3625C>T; GRCh37 chr1:27106114. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "ARID1A|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ARID1A+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "ARID1A": 0.2762992755625062
      },
      "clinical_evidence": {
        "pmid": "30510156",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_073",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.6334293589307343
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_074",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "ARID1A",
        "hgvs_p": "p.Arg1209Ter",
        "chrom": "1",
        "pos": 27106114,
        "ref": "G",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_006015.6(ARID1A):c.3625C>T; GRCh37 chr1:27106114. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "ARID1A|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ARID1A+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "ARID1A": 0.2596675073474911
      },
      "clinical_evidence": {
        "pmid": "30510156",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_075",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.48274278092286904
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_076",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+WEE1"
      ],
      "effective_drugs": [
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_077",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.48274278092286904
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_078",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "MBD4",
        "hgvs_p": "p.Trp569Ter",
        "chrom": "3",
        "pos": 129150847,
        "ref": "G",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_003925.3(MBD4):c.1706G>A (p.Trp569*); GRCh37 chr3:129150847.",
        "_mapping_key": "MBD4|p.R346fs",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "MBD4+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "BER"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "MBD4": 0.12484960719544597
      },
      "clinical_evidence": {
        "pmid": "30111527",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_079",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "ARID1A",
        "hgvs_p": "p.Arg1209Ter",
        "chrom": "1",
        "pos": 27106114,
        "ref": "G",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_006015.6(ARID1A):c.3625C>T; GRCh37 chr1:27106114. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "ARID1A|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "ARID1A+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "ARID1A": 0.2596675073474911
      },
      "clinical_evidence": {
        "pmid": "30510156",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_080",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.42475616619423795
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_081",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "33115855",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_082",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+WEE1"
      ],
      "effective_drugs": [
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_083",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+WEE1"
      ],
      "effective_drugs": [
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_084",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "PALB2",
        "hgvs_p": "p.Arg1086Ter",
        "chrom": "16",
        "pos": 23641422,
        "ref": "A",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_024675.4(PALB2):c.3256C>T; GRCh37 chr16:23641422; ClinVar VCV000126729. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "PALB2|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "PALB2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "PALB2": 0.4837245019947514
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_085",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51D",
        "hgvs_p": "p.Ser207Leu",
        "chrom": "17",
        "pos": 33428695,
        "ref": "G",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_002878.4(RAD51D):c.620C>T; GRCh37 chr17:33428695. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "RAD51D|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51D+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51D": 0.7293221853155034
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_086",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+WEE1"
      ],
      "effective_drugs": [
        "Adavosertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_087",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.42475616619423795
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_088",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.48274278092286904
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_089",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51D",
        "hgvs_p": "p.Ser207Leu",
        "chrom": "17",
        "pos": 33428695,
        "ref": "G",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_002878.4(RAD51D):c.620C>T; GRCh37 chr17:33428695. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "RAD51D|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51D+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51D": 0.7360546282435787
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_090",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "TP53",
        "hgvs_p": "p.R175H",
        "chrom": "17",
        "pos": 7578406,
        "ref": "A",
        "alt": "C",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_000546.6(TP53):c.524G>A; genomic Chr17:7578406 on GRCh37, ClinVar RCV000131301 / VCV000012374",
        "_mapping_key": "TP53|p.R175H",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "TP53+ATR"
      ],
      "effective_drugs": [
        "Ceralasertib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "ATR/CHK1"
      ],
      "depmap_essentiality": {
        "TP53": 0.0
      },
      "clinical_evidence": {
        "pmid": "33115855",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_091",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA1",
        "hgvs_p": "p.C61G",
        "chrom": "17",
        "pos": 41258504,
        "ref": "G",
        "alt": "A",
        "consequence": "missense",
        "build": "GRCh38",
        "_mapping_note": "NM_007294.4(BRCA1):c.181T>G (p.C61G); genomic Chr17:41258504 on GRCh37",
        "_mapping_key": "BRCA1|p.C61G",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA1+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA1": 0.5136549385283461
      },
      "clinical_evidence": {
        "pmid": "28569902",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_092",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "BRCA2",
        "hgvs_p": "p.K3326*",
        "chrom": "13",
        "pos": 32340314,
        "ref": "C",
        "alt": "A",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_000059.4(BRCA2):c.9976A>T (p.K3326*); genomic Chr13:32340314 on GRCh37",
        "_mapping_key": "BRCA2|p.K3326*",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "BRCA2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "HR"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "BRCA2": 0.49663622684497655
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "FDA"
      }
    }
  },
  {
    "case_id": "SL_093",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.48274278092286904
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_094",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51D",
        "hgvs_p": "p.Ser207Leu",
        "chrom": "17",
        "pos": 33428695,
        "ref": "G",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_002878.4(RAD51D):c.620C>T; GRCh37 chr17:33428695. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "RAD51D|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51D+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51D": 0.5788916280524823
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_095",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.7042390620749244
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_096",
    "disease": "breast_cancer",
    "subtype": "triple_negative",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.7042390620749244
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_097",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "CDK12",
        "hgvs_p": "p.Arg882His",
        "chrom": "17",
        "pos": 37618363,
        "ref": "A",
        "alt": "C",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_016507.4(CDK12):c.2645G>A; GRCh37 chr17:37618363. [AUTOREF 2026-01-19 ref:G->A]",
        "_mapping_key": "CDK12|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "CDK12+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "CDK12": 0.4085607197529356
      },
      "clinical_evidence": {
        "pmid": "31320749",
        "evidence_level": "Preclinical"
      }
    }
  },
  {
    "case_id": "SL_098",
    "disease": "ovarian_cancer",
    "subtype": "high_grade_serous",
    "stage": "?",
    "mutations": [
      {
        "gene": "PALB2",
        "hgvs_p": "p.Arg1086Ter",
        "chrom": "16",
        "pos": 23641422,
        "ref": "A",
        "alt": "T",
        "consequence": "stop_gained",
        "build": "GRCh38",
        "_mapping_note": "NM_024675.4(PALB2):c.3256C>T; GRCh37 chr16:23641422; ClinVar VCV000126729. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "PALB2|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "PALB2+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "PALB2": 0.33189795944643924
      },
      "clinical_evidence": {
        "pmid": "32592347",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_099",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51D",
        "hgvs_p": "p.Ser207Leu",
        "chrom": "17",
        "pos": 33428695,
        "ref": "G",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_002878.4(RAD51D):c.620C>T; GRCh37 chr17:33428695. [AUTOREF 2026-01-19 ref:C->G]",
        "_mapping_key": "RAD51D|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51D+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51D": 0.5788916280524823
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  },
  {
    "case_id": "SL_100",
    "disease": "prostate_cancer",
    "subtype": "mCRPC",
    "stage": "?",
    "mutations": [
      {
        "gene": "RAD51C",
        "hgvs_p": "p.Arg312Trp",
        "chrom": "17",
        "pos": 56770906,
        "ref": "A",
        "alt": "T",
        "consequence": "missense_variant",
        "build": "GRCh38",
        "_mapping_note": "NM_058216.2(RAD51C):c.934C>T; GRCh37 chr17:56770906. [AUTOREF 2026-01-19 ref:C->A]",
        "_mapping_key": "RAD51C|p.?",
        "_hydration": {
          "ok": true,
          "method": "already_complete",
          "note": null
        }
      }
    ],
    "ground_truth": {
      "synthetic_lethality_detected": true,
      "known_sl_pairs": [
        "RAD51C+PARP1"
      ],
      "effective_drugs": [
        "Olaparib",
        "Niraparib"
      ],
      "broken_pathways": [
        "G1/S Checkpoint"
      ],
      "essential_pathways": [
        "PARP"
      ],
      "depmap_essentiality": {
        "RAD51C": 0.6334293589307343
      },
      "clinical_evidence": {
        "pmid": "30345854",
        "evidence_level": "Phase2"
      }
    }
  }
]